Actinium Pharmaceuticals Inc (ATNM)
$6.96
0.00 (0.00%)
3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns
These are the clinical-stage biotech stocks to buy, as they represent companies with an attractive product pipeline.
Top 5 Stocks for 2024
![](https://investorplace.com/wp-content/plugins/lazy-load/images/1x1.trans.gif)
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
![](https://investorplace.com/wp-content/themes/InvestorPlaceV2/dist/images/analysts_thumb_louis_navellier_new_tiny.jpg)
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
148.47M
PE Ratio
-4.07
EPS
-1.71
Volume (Avg. Vol.)
Day's Range
-
52-Week Range
$4.00 - $10.24
Dividend & Yield
N/A (N/A)